{"id":"W3090112611","doi":"10.3390/ijms21197268","title":"Targeted Molecular Therapeutics for Bladder Cancer—A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?","year":2020,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Bladder cancer; Chemotherapy; Oncology; Adverse effect; Immunotherapy; Cancer; Internal medicine; Monoclonal antibody; Antibody; Cancer research; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001933946,0.0005010451,0.001021727,0.0006969971,0.0004026571,0.002145971,0.0009286087,0.002057808,0.007494348],"category_scores_gemma":[0.001241822,0.0002244671,0.0006943409,0.0004601916,0.001509018,0.00586741,0.00142713,0.004544237,0.002395797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008812682,"about_ca_system_score_gemma":0.0008518618,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004247403,"about_ca_topic_score_gemma":0.001573664,"domain_scores_codex":[0.9994738,0.0001406589,0.00002601927,0.00007726693,0.000184153,0.00009819542],"domain_scores_gemma":[0.999355,0.0002335856,0.00008963816,0.000038826,0.0001445555,0.0001384285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008639741,0.0005513763,0.0007665585,0.002993908,0.0001884247,0.0007765825,0.0002891382,0.001059119,0.01954274,0.09101714,0.1266991,0.755252],"study_design_scores_gemma":[0.0002643482,0.001527384,0.000871537,0.001289559,0.0001027188,0.00137149,0.0002331107,0.001175843,0.003619056,0.04419924,0.9452758,0.00006985657],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008626942,0.8447151,0.007502286,0.1214836,0.004967415,0.00005103213,0.0001796076,0.0002078245,0.01226617],"genre_scores_gemma":[0.07673497,0.8390219,0.0068484,0.05030918,0.00966353,0.0001418201,0.0002753713,0.00009152414,0.01691331],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007494348,"threshold_uncertainty_score":0.02507114,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05481355308453748,"score_gpt":0.3767134574986533,"score_spread":0.3218999044141158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}